Refine Results
- view as grid
- view as list
It May Be Time To Waive Patients’ Costs for Coronavirus Treatment
Drew Altman looks at the numbers for COVID-19 treatment, and why it may soon be necessary for Congress to waive out-of-pocket costs for treatment.
Perspective Read More
Even Supporters May Not Understand Medicare-for-All
In this Axios column, Drew Altman shows that the majority of supporters don’t know how Medicare-for-all works, with both positive and negative implications for support if they knew more.
Perspective Read More
Tracking the Role of Health Care in the 2020 Election: What Do The Polls Tell Us
In this February 2020 post for The JAMA Health Forum, Mollyann Brodie and Ashley Kirzinger examine the role health care has played in the primary election to date, what the polling data says about the issue, including Medicare-for-all and a public option, and what to expect from the issue during the rest of the 2020 election campaign.
Perspective Read More
Republican Voters Have Moved On from Hating the ACA
In this Axios column, Drew Altman analyzes KFF’s tracking poll and shows that the ACA is now yesterday’s issue for Republicans. They have shifted their sights to Medicare-for-all…at least for this election season.
Perspective Read More
What Iowa and New Hampshire tell us about Medicare-for-All
In this Axios column, Drew Altman analyzes data from the New Hampshire exit poll showing that support for Medicare-for-all played a role in the primary while broader support for a more moderate plan may be a signal about the general election.
Perspective Read More
JAMA Forum: Don’t Be Surprised if the Next Big Health Care Debate Is About Drug Prices
In this post for The JAMA Forum, Larry Levitt examines both the Democratic candidates’ proposals and the Trump administration’s record on lowering drug prices, which remains a top issue for the public with bi-partisan support.
Perspective Read More
Self-insured Companies Do No Better on Cost Control
A data surprise? Drew Altman, in his latest Axios column, shows there is no difference between large self-insured and fully insured companies when it comes to controlling health care costs, bucking conventional wisdom.
Perspective Read More
The ACA is Doing Fine Without a Mandate Penalty
In an Axios column, Drew Altman explains that the elimination of the Affordable Care Act’s individual mandate penalty has had little impact on how the ACA’s insurance markets are working, showing that “the marketplaces continue to function, even when ‘severed’ from the mandate penalty,” and undercutting a central argument in the lawsuit seeking to strike down the entire law.
Perspective Read More
Health Policy in 2020 Will Be Made in the States
With a questionable outlook for 2020 passage of legislation on prescription drug pricing and surprise medical bills, Drew Altman says the real action to watch in health policy is likely to be in the states.
Perspective Read More
Private Insurance’s Costs are Skyrocketing
In this Axios column, Drew Altman takes a long-term view of the recently released federal data on health spending showing that spending for private insurance is rising much faster than for Medicare and Medicaid, and predicts rising pressure in the health care industry as a result.
Perspective Read More